Glypro 0.2 mg/ml Injection 1 ml belongs to the group of medications called 'anticholinergics' indicated in anaesthesia for reduction of airway or gastric secretions, volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anaesthesia and intubation, for protection against peripheral muscarinic effects of cholinergic agents, and intraoperatively to counteract surgically or drug-induced or vagal reflex associated arrhythmias. It is also used as adjunctive therapy for treating peptic ulcers. 

Glypro 0.2 mg/ml Injection 1 ml contains 'Glycopyrrolate', which works by inhibiting the action of acetylcholine. Thus, reduces gastric secretions' volume and free acidity and controls excessive pharyngeal, bronchial, and tracheal secretions.

Glypro 0.2 mg/ml Injection 1 ml will be administered by a healthcare professional; do not self-administer. In some cases, Glypro 0.2 mg/ml Injection 1 ml may cause dry mouth, urinary retention and hesitancy, blurred vision, palpitations, and decreased sweating. Most of these side effects of Glypro 0.2 mg/ml Injection 1 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Inform your doctor if you are allergic to any components in Glypro 0.2 mg/ml Injection 1 ml. Consult your doctor if you are pregnant or breastfeeding. Glypro 0.2 mg/ml Injection 1 ml may cause drowsiness and blurred vision, do not drive or operate machinery unless you are alert. Let your doctor know if you are taking prescription and non-prescription medications, including vitamins and herbal supplements.

Glypro 0.2 mg/ml Injection 1 ml belongs to the group of medications called 'anticholinergics' indicated in anaesthesia for reduction of airway or gastric secretions, volume and acidity of gastric secretions, and blockade of cardiac inhibitory reflexes during induction of anaesthesia and intubation, intraoperatively to counteract surgically or drug-induced or vagal reflex associated arrhythmias, and for protection against peripheral muscarinic effects of cholinergic agents. It is also used as adjunctive therapy for treating peptic ulcers when an immediate anti-cholinergic effect is desired or oral medication is not feasible. Glypro 0.2 mg/ml Injection 1 ml contains 'Glycopyrrolate', which works by inhibiting the action of acetylcholine. Thus, reduces gastric secretions' volume and free acidity and controls excessive pharyngeal, bronchial, and tracheal secretions.

Do not take Glypro 0.2 mg/ml Injection 1 ml if you are allergic to any components. Inform your doctor if you have glaucoma, gastrointestinal obstruction, obstructive uropathy, paralytic ileus (intestinal obstruction), debilitated (weak), severe/complicated ulcerative colitis, toxic megacolon, myasthenia gravis (muscle problems), coronary artery disease, cardiac arrhythmia, congestive heart failure, high blood pressure, hyperthyroidism, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.

Peptic ulcers:

• Eat smaller meals more often.
• Avoid smoking and alcohol consumption.
• Maintain a healthy weight by regular exercising.
• Avoid lying down after eating to prevent acid reflux.
• Avoid tight-fitting clothes as it might increase the pressure on the abdomen leading to acid reflux.
• Practice relaxation techniques and avoid stress by doing yoga or meditation.
• Avoid foods such as high-fat, spicy chocolates, citrus fruits, pineapple, tomato, onion, garlic, tea, and soda.
• Avoid sitting continuously, as it may trigger acidity. Take a break of 5 minutes every hour by brisk walking or stretching.

• Dry mouth
• Urinary retention and hesitancy
• Blurred vision
• Decreased sweating
• Palpitations

Peptic ulcers: Peptic ulcers are sores that develop on the lining of the stomach and intestine due to erosion of the stomach's protective lining. Symptoms include nausea, changes in appetite, bloody or dark stools, unexplained weight loss, vomiting, and indigestion.